EUROPEAN JOURNAL OF HEART FAILURE
Scope & Guideline
Fostering excellence in heart failure research and education.
Introduction
Aims and Scopes
- Heart Failure Mechanisms and Pathophysiology:
Research exploring the biological mechanisms underlying heart failure, including genetic, molecular, and cellular factors that contribute to disease progression. - Clinical Management and Treatment Strategies:
Studies evaluating the efficacy and safety of various treatment modalities, including pharmacological therapies, device interventions, and lifestyle changes for heart failure patients. - Epidemiology and Risk Factors:
Investigations into the prevalence, incidence, and risk factors associated with heart failure across different populations, with an emphasis on comorbidities and demographic influences. - Diagnostic Approaches:
Research focused on the development and validation of diagnostic tools and biomarkers for the early detection and accurate classification of heart failure. - Health Economics and Patient Outcomes:
Analysis of healthcare resource utilization, cost-effectiveness of treatments, and the impact of heart failure on quality of life and long-term outcomes. - Innovative Technologies:
Studies on the application of new technologies, such as telemedicine, remote monitoring, and machine learning, to enhance heart failure management and patient care.
Trending and Emerging
- Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors:
A notable increase in research surrounding SGLT2 inhibitors as a treatment option for heart failure, highlighting their multifaceted benefits beyond glycemic control. - Heart Failure with Preserved Ejection Fraction (HFpEF):
Growing attention on HFpEF, with an emphasis on understanding its unique pathophysiology, diagnostic criteria, and treatment challenges. - Telemedicine and Remote Monitoring:
Emerging themes in the utilization of telemedicine and remote monitoring technologies for managing heart failure, particularly in light of the COVID-19 pandemic. - Machine Learning and Artificial Intelligence:
Increasing integration of machine learning and AI in predicting heart failure outcomes, enhancing diagnostics, and personalizing treatment strategies. - Comorbidities and Multimorbidity:
A trend towards understanding the interplay between heart failure and other chronic conditions, focusing on comprehensive care approaches that address multiple comorbidities. - Patient-Centered Care and Quality of Life:
A shift towards research that emphasizes patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with heart failure.
Declining or Waning
- Traditional Pharmacotherapy Alone:
There seems to be a diminishing focus on studies solely centered around traditional pharmacological treatments for heart failure, with increasing interest in combination therapies and innovative approaches. - Generalized Heart Failure Definitions:
The use of broad, non-specific definitions of heart failure is becoming less prominent, as more precise phenotyping and tailored approaches are being favored in recent research. - Single-Center Studies:
The prevalence of single-center studies is declining in favor of multi-center and large cohort studies, which provide more generalizable findings and insights into heart failure management. - Basic Science without Clinical Relevance:
Research that lacks direct clinical applicability or insights into patient care is receiving less attention, as the journal increasingly prioritizes studies that bridge laboratory findings with clinical implications.
Similar Journals
International Heart Journal
Driving Progress in Cardiology and Patient OutcomesInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.
Cardiology Research and Practice
Innovative insights shaping the future of cardiology.Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.
International Journal of Chronic Obstructive Pulmonary Disease
Unlocking Innovations in Respiratory HealthThe International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.
Cardiovascular Innovations and Applications
Advancing cardiovascular knowledge for a healthier tomorrow.Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.
Current Heart Failure Reports
Shaping the Future of Heart Failure TreatmentsCurrent Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.
Journal of Cardiology
Connecting researchers and clinicians in the fight against heart disease.Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.
Journal of Cardiovascular Medicine
Uncovering Breakthroughs in CardiologyWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.
CURRENT PROBLEMS IN CARDIOLOGY
Driving Progress in Heart Health ResearchCURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.
Korean Circulation Journal
Connecting Researchers and Practitioners for Heart Health Advancements.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.
HEART AND VESSELS
Pioneering Research in Heart Health and Vascular FunctionHEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.